EICHOR
● Active Not Recruiting
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
Condition: Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification · Lung Adenocarcinoma Stage IIIB/IV · Sponsor: EMD Serono Research & Development Institute, Inc.
About this study
This study looked at how effective the study drug (tepotinib) was at stopping the growth and spread of lung cancer. This study also measures a number of other things including safety of the study drug and the side effects, how body processes the study drug, or how the study drug affects your quality of life. The study also has an optional pharmacogenetic research part. Pharmacogenetic research is an important way to try to understand the role of genetics in human disease and how genes impact the effectiveness of drugs, because differences in genes can change the way a person responds to a particular drug.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (176)
| City of Hope Cancer Center | Duarte, California, United States | — |
| California Cancer Associates for Research & Excellence, Inc. | Encinitas, California, United States | — |
| St. Joseph Hospital | Orange, California, United States | — |
| Torrance Health Association | Redondo Beach, California, United States | — |
| St Joseph Heritage Healthcare | Santa Rosa, California, United States | — |
| Rocky Mountain Cancer Centers, LLP | Denver, Colorado, United States | — |
| Holy Cross Hospital Inc. | Fort Lauderdale, Florida, United States | — |
| H. Lee Moffitt Cancer Center and Research Institute, Inc | Tampa, Florida, United States | — |
| University Cancer & Blood Center, LLC | Athens, Georgia, United States | — |
| Winship Cancer Institute | Atlanta, Georgia, United States | — |
| University of Chicago Medical Center | Chicago, Illinois, United States | — |
| Ingalls Hospital | Harvey, Illinois, United States | — |
+ 164 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02864992